Study reveals new liquid biopsy test could benefit thousands of lung cancer patients
The third most common and serious form of cancer affects over 43,000 people every year in the UK
Read More
Tag: The Royal Marsden
£50 blood test could predict prostate cancer drug response
Researchers have developed a blood test that could better tailor the treatment of patients with prostate cancer.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
